{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Livonia",
      "state": "MI",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89663",
      "recalling_firm": "The Harvard Drug Group",
      "address_1": "17187 N Laurel Park Dr Ste 300",
      "address_2": "N/A",
      "postal_code": "48152-2600",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within USA",
      "recall_number": "D-0653-2022",
      "product_description": "hydrALAZINE HCl Tablets, USP, 10 mg, 100 Tablets per carton (10x10 blister packs), Rx only, Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152 USA. NDC # 0904-6440-61",
      "product_quantity": "5,953 cartons",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification result obtained during routine stability testing for Impurities.",
      "recall_initiation_date": "20220224",
      "center_classification_date": "20220314",
      "termination_date": "20230716",
      "report_date": "20220323",
      "code_info": "Lot #: T03755, T03756, Exp. Date 03/2023"
    }
  ]
}